Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Revista de la Sociedad Española del Dolor
versión impresa ISSN 1134-8046
Resumen
RODRIGUEZ, R.F. y CAICEDO, M.L.. Validation of the second step of the WHO analgesic ladder: is the use of weak opioids necessary?. Rev. Soc. Esp. Dolor [online]. 2013, vol.20, n.6, pp.285-290. ISSN 1134-8046. https://dx.doi.org/10.4321/S1134-80462013000600002.
Objective: Compare the analgesic efficacy and tolerability of acetaminophen versus acetaminophen plus codeine in the relief of cancer-related pain. Methods: This 7-day, prospective, double-blind, randomized, parallel-group study was conducted with 36 patients with cancer pain. Outpatients were eligible for the study if they were aged ≥ 18 years and had moderate to severe cancer-related pain. Eligible patients were randomly assigned to receive acetaminophen or acetaminophen plus codeine. The primary end point was the proportion of patients who achieved pain relief; the second end point was time to achieve relief pain. Results: Of the 36 patients who participated, 20 received acetaminophen and 16 acetaminophen plus codeine. At baseline there were not differences between the groups. None of the between-group differences in response rates were significant (p > 0,05). The most common adverse effect in codeine group was constipation (p = 0,001). Conclusion: Efficacy was comparable between acetaminophen and acetaminophen plus codeine over 7 days of treatment in this patients with moderate or severe cancer-related pain. Codeine was associated with significantly greater constipation.
Palabras clave : Codeine; Acetaminophen; Analgesic ladder; Pain; Cancer.